Overview

A Study of MF101 in Postmenopausal Women

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This phase 3a study is designed to assess the safety and efficacy of MF101 on the frequency of moderate to severe hot flushes in postmenopausal women.

Phase:

Phase 3

Details

Lead Sponsor:

Bionovo